Faraday Pharmaceuticals, Inc.
Clinical trials sponsored by Faraday Pharmaceuticals, Inc., explained in plain language.
-
New drug aims to shield heart attack patients from dangerous rhythms
Disease control CompletedThis study tested an experimental drug called FDY-5301 in 120 adults who had a severe type of heart attack (STEMI) and were undergoing a procedure to open blocked arteries. The goal was to see if the drug could reduce dangerous heart rhythm problems and limit heart muscle damage …
Phase: PHASE2 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 02, 2026 15:14 UTC
-
New drug aims to save hearts after massive attack
Disease control CompletedThis study tested an experimental drug called FDY 5301 in over 2,300 people who had a severe type of heart attack (anterior STEMI) and were undergoing emergency artery-opening treatment. The goal was to see if the drug could lower the chance of dying from heart problems or develo…
Phase: PHASE3 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 02, 2026 15:03 UTC